Development of New Therapeutic Materials for Mitigation of Amyloid Neurotoxicity Associated with Alzheimer’s Disease

dc.contributor.authorMondal, Subrata
dc.date.accessioned2023-10-06T07:28:56Z
dc.date.accessioned2023-10-19T12:13:01Z
dc.date.available2023-10-06T07:28:56Z
dc.date.available2023-10-19T12:13:01Z
dc.date.issued2022
dc.descriptionSupervisor: Iyer, P. K.en_US
dc.description.abstractAlzheimer’s disease (AD), an irreversible brain disorder, first diagnosed more than 100 years ago, still remains a curse to the society, affecting 30 million people worldwide, victimizing one in ten individuals above 65 years’ age, due to lack of efficient therapeutic strategy. Intense research activity suggests that amyloid fibrils originating from self-aggregation of amyloid β peptide having cross-β sheeted conformation are the hallmark of this disease. Hence, inhibition of amyloid aggregation can offer a platform to develop early stage therapeutics against several neurodegenerative diseases including AD.en_US
dc.identifier.otherROLL NO.156122003
dc.identifier.urihttps://gyan.iitg.ac.in/handle/123456789/2466
dc.language.isoenen_US
dc.relation.ispartofseriesTH-2780;
dc.subjectAmyloiden_US
dc.subjectAlzheimer Diseaseen_US
dc.subjectProtein Misfoldingen_US
dc.subjectAmyloid Kineticsen_US
dc.titleDevelopment of New Therapeutic Materials for Mitigation of Amyloid Neurotoxicity Associated with Alzheimer’s Diseaseen_US
dc.typeThesisen_US
Files
Original bundle
Now showing 1 - 2 of 2
No Thumbnail Available
Name:
Abstract-TH-2780_156122003.pdf
Size:
134.72 KB
Format:
Adobe Portable Document Format
Description:
ABSTRACT
No Thumbnail Available
Name:
TH-2780_156122003.pdf
Size:
9.66 MB
Format:
Adobe Portable Document Format
Description:
THESIS
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description: